Lanthi-galanin

N/A

Report date: 2025/03/20 14:49:35

Base Information

Drug NameLanthi-galanin
Drug Alias Namegalanin 2 agonist peptide (Lanthio Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGalanin receptor type 2 agonists
TargetsGalanin receptor type 2
Therapy Area/IndicationsEpilepsyMultiple SclerosisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLanthio Pharma Bv
China Registration ClassN/A

Develop Information

Active CompaniesLanthio Pharma Bv
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsEpilepsyInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A